SLDB

Solid Biosciences (SLDB)

Solid Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SLDB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/20	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SLDB	Solid Biosciences Inc
2024/05/15	21:26	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:SLDB	Solid Biosciences Inc
2024/05/15	20:52	GlobeNewswire Inc.	Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results	NASDAQ:SLDB	Solid Biosciences Inc
2024/05/15	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SLDB	Solid Biosciences Inc
2024/05/07	20:00	GlobeNewswire Inc.	Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting	NASDAQ:SLDB	Solid Biosciences Inc
2024/05/07	07:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/05/03	05:05	GlobeNewswire Inc.	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:SLDB	Solid Biosciences Inc
2024/04/04	05:05	GlobeNewswire Inc.	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:SLDB	Solid Biosciences Inc
2024/04/01	20:45	GlobeNewswire Inc.	Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003	NASDAQ:SLDB	Solid Biosciences Inc
2024/03/27	20:00	GlobeNewswire Inc.	Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposium	NASDAQ:SLDB	Solid Biosciences Inc
2024/03/13	20:44	GlobeNewswire Inc.	Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results	NASDAQ:SLDB	Solid Biosciences Inc
2024/03/07	21:00	GlobeNewswire Inc.	Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD	NASDAQ:SLDB	Solid Biosciences Inc
2024/03/06	22:00	GlobeNewswire Inc.	Solid Biosciences to Participate at Upcoming Investor Conferences	NASDAQ:SLDB	Solid Biosciences Inc
2024/02/17	02:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/02/17	01:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/02/17	01:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/02/17	01:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/02/17	01:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/02/17	00:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/02/09	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/31	07:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/31	06:09	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/20	09:23	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/16	22:50	Dow Jones News	Solid Biosciences Gets Orphan Drug Designation for SGT-003	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/16	22:00	GlobeNewswire Inc.	Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/13	07:05	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/12	07:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/11	06:31	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/08	21:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLDB	Solid Biosciences Inc
2024/01/08	21:09	GlobeNewswire Inc.	Solid Biosciences Announces $109 Million Private Placement	NASDAQ:SLDB	Solid Biosciences Inc